Highlighted Research Trials and Studies
Go to CLINICALTRIALS.GOV for a more comprehenisive list of ongoing studies and trials.
Stanford Ophthalmology, Children's hospital of Philadelphia and Gilbert Family Foundation
| 2024
This study is seeking to learn how different eye tests and devices can…
Johns Hopkins Comprehensive NF Center
Researchers at Johns Hopkins and around the world are investigating ways to slow…
Massachusetts's General Hospital
| 2024
If you or your child has NF1, and you don't go to an…
University of Wisconsin-Milwaukee
| 2023
By Dr. Bonnie Klein-Tasman
Dana-Farber/Boston Children's
| 2024
The Neurofibromatosis Type 1 Tumor Early Detection (NF1-TED) study will determine whether a…
NFlection Therapeutics
| 2023
Phase two trial is done. A phase three trial may open soon. Latest…
Ann & Robert H. Luries Childrens Hospital of Chicago
| 2023
By Carlos Prada, MD
Recruiting NF1 individuals with known Plexiform Neurofibromas
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
University of Wisconsin-Milwaukee
| 2021
By Bonnie Klein-Tasman, PhD
Recursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the…
Johns Hopkins Comprehensive NF Center
Researchers at Johns Hopkins and around the world are investigating ways to slow…
2024 NF Midwest iNFO Fair
| 2024
By Vanessa Merker, PhD
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
Johns Hopkins Comprehensive NF Center
Researchers at Johns Hopkins and around the world are investigating ways to slow…
Massachusetts General Hospital/Harvard
| 2022
By Julie Brewer
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.
.png)
